"I found a treatment that's a match for me."
The first treatment specifically for metastatic non-small cell lung cancer (mNSCLC) with an abnormality in the MET gene called MET exon 14 skipping (METex14).
The first treatment specifically for metastatic non-small cell lung cancer (mNSCLC) with an abnormality in the MET gene called MET exon 14 skipping (METex14).
TABRECTA may cause serious side effects. Tell your health care provider right away if you get any of the following:
TABRECTA is a prescription medicine used to treat adults with a kind of lung cancer called non-small cell lung cancer (NSCLC) that: